Please assess the completion status of the following clinical trial:

Trial Title: Watch and Wait After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically verified adenocarcinoma of the rectum within 15 cm from the anal verge measured by rigid proctoscopy~* Patients who have completed neoadjuvant treatment according to national guidelines for rectal cancer, i.e., radiotherapy or chemo-radiotherapy (at least 40 Gy) or short-course radiotherapy combined with chemotherapy~* Patients aged ≥18 years of age are eligible for inclusion. However, patients aged ≤40 years are recommended to undergo surgery on the theoretical base of a possibly more aggressive tumour disease in this age group, and will be asked to participate in the study by consenting to recording of data. Those patients who insist on W\&W approach after careful consideration and well-documented informed consent are eligible for entering the W\&W protocol.~* Given informed consent~* Stage I-III rectal cancer; however, patients with limited liver metastases who undergo primary liver surgery as part of a liver first treatment approach may be included~Exclusion Criteria:~* Patients without cCR~* Patients unable to give informed consent~* Patients with short course radiotherapy (5x5 Gy) without additional chemotherapy, or patients receiving less than 40 Gy in long course CRT~* Patients with cCR but with increasing tumour growth on MRI after preoperative treatment~* Patients with metastatic disease at the time of diagnosis with the exception of those who are eligible for liver first treatment approach as part of an intention to cure approach.~* Patients previously diagnosed and treated for malignant disease in the pelvic region with radio- or chemoradiotherapy~* Other circumstances that may interfere with successful participation in the W\&W protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).